
Keywords: Type 1 diabetes; Plasma matrix; Perfluorodecalin; IBMIR; Intraportal transplantation; ECM; extra-cellular matrix; ePFD; Emulsified perfluorodecalin; FAK; Focal Adhesion Kinase; FDA; Fluorescein Diacetate; HIF-1α; Hypoxia-inducible factor 1α; IBMIR; Inst